Diagnosing epidermolysis bullosa type and subtype in infancy using immunofluorescence microscopy: The stanford experience

Pediatric Dermatology

Volumn 30, Issue 2, 2013, Pages 226-233

  Berk, David R ^a   Jazayeri, Leila ^b   Marinkovich, M Peter ^b   Sundram, Uma N ^b   Bruckner, Anna L ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL EVALUATION; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DYSTROPHY; EPIDERMOLYSIS BULLOSA; HUMAN; IMMUNOFLUORESCENCE MICROSCOPY; INFANCY; INFANT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SKIN DISEASE; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84874834680     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2012.01880.x     Document Type: Article

References (34)

1. Fine JD, Eady RA, Bauer EA, et al. The classification of inherited epidermolysis bullosa (EB): report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 2008; 58: 931-950.
2. Fine JD, Johnson LB, Weiner M, et al. Cause-specific risks of childhood death in inherited epidermolysis bullosa. J Pediatr 2008; 152: 276-280.
3. Sybert VP,. Genetic counseling in epidermolysis bullosa. Dermatol Clin 2010; 28: 239-243.
4. Pearson RW,. Studies on the pathogenesis of epidermolysis bullosa. J Invest Dermatol 1962; 39: 551-575.
5. Eady RA, Dopping-Hepenstal PJ,. Transmission electron microscopy for the diagnosis of epidermolysis bullosa. Dermatol Clin 2010; 28: 211-222, vii.
6. Pohla-Gubo G, Cepeda-Valdes R, Hintner H,. Immunofluorescence mapping for the diagnosis of epidermolysis bullosa. Dermatol Clin 2010; 28: 201-210, vii.
7. Rousselle P, Lunstrum GP, Keene DR, et al. Kalinin: an epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments. J Cell Biol 1991; 114: 567-576.
8. Marinkovich MP, Lunstrum GP, Keene DR, et al. The dermal-epidermal junction of human skin contains a novel laminin variant. J Cell Biol 1992; 119: 695-703.
9. Marinkovich MP, Taylor TB, Keene DR, et al. LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells. J Invest Dermatol 1996; 106: 734-738.
10. Petronius D, Bergman R, Ben Izhak O, et al. A comparative study of immunohistochemistry and electron microscopy used in the diagnosis of epidermolysis bullosa. Am J Dermatopathol 2003; 25: 198-203.
11. Yiasemides E, Walton J, Marr P, et al. A comparative study between transmission electron microscopy and immunofluorescence mapping in the diagnosis of epidermolysis bullosa. Am J Dermatopathol 2006; 28: 387-394.
12. Fine JD, Smith LT,. Nonmolecular diagnostic testing of inherited epidermolysis bullosa. In:, Fine JD, Bauer EA, McGuire J, et al, eds. Epidermolysis Bullosa: Clinical, Epidemiologic, and Laboratory Advances and the Findings of the National Epidermolysis Bullosa Registry. Baltimore, MD: Johns Hopkins University Press, 1999: 48.
13. Smith FJ, Eady RA, Leigh IM, et al. Plectin deficiency results in muscular dystrophy with epidermolysis bullosa. Nat Genet 1996; 13: 450-457.
14. Pfendner EG, Bruckner A, Conget P, et al. Basic science of epidermolysis bullosa and diagnostic and molecular characterization: Proceedings of the IInd International Symposium on Epidermolysis Bullosa, Santiago, Chile, 2005. Int J Dermatol 2007; 46: 781-794.
15. Frew JW, Dopping-Hepenstal PJ, McGrath JA,. Categorizing immunofluorescence mapping in epidermolysis bullosa with pyloric atresia: use as a broad prognostic indicator. Australas J Dermatol 2010; 51: 212-214.
16. McGrath JA, Gatalica B, Li K, et al. Compound heterozygosity for a dominant glycine substitution and a recessive internal duplication mutation in the type XVII collagen gene results in junctional epidermolysis bullosa and abnormal dentition. Am J Pathol 1996; 148: 1787-1796.
17. McGrath JA, Kivirikko S, Ciatti S, et al. A recurrent homozygous nonsense mutation within the LAMA3 gene as a cause of Herlitz junctional epidermolysis bullosa in patients of Pakistani ancestry: evidence for a founder effect. J Invest Dermatol 1996; 106: 781-784.
18. Aberdam D, Galliano MF, Vailly J, et al. Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the gamma 2 subunit of nicein/kalinin (LAMININ-5). Nat Genet 1994; 6: 299-304.
19. Kivirikko S, McGrath JA, Baudoin C, et al. A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa. Hum Mol Genet 1995; 4: 959-962.
20. Pulkkinen L, Christiano AM, Gerecke D, et al. A homozygous nonsense mutation in the beta 3 chain gene of laminin 5 (LAMB3) in Herlitz junctional epidermolysis bullosa. Genomics 1994; 24: 357-360.
21. Pulkkinen L, Christiano AM, Airenne T, et al. Mutations in the gamma 2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bullosa. Nat Genet 1994; 6: 293-297.
22. Schofield OM, Fine JD, Verrando P, et al. GB3 monoclonal antibody for the diagnosis of junctional epidermolysis bullosa: results of a multicenter study. J Am Acad Dermatol 1990; 1: 1078-1083.
23. McMillan JR, McGrath JA, Pulkkinen L, et al. Immunohistochemical analysis of the skin in junctional epidermolysis bullosa using laminin 5 chain specific antibodies is of limited value in predicting the underlying gene mutation. Br J Dermatol 1997; 136: 817-822.
24. Jonkman MF, de Jong MC, Heeres K, et al. Generalized atrophic benign epidermolysis bullosa. Either 180-kd bullous pemphigoid antigen or laminin-5 deficiency. Arch Dermatol 1996; 132: 145-150.
25. McGrath JA, Pulkkinen L, Christiano AM, et al. Altered laminin 5 expression due to mutations in the gene encoding the beta 3 chain (LAMB3) in generalized atrophic benign epidermolysis bullosa. J Invest Dermatol 1995; 104: 467-474.
26. Meneguzzi G, Marinkovich MP, Aberdam D, et al. Kalinin is abnormally expressed in epithelial basement membranes of Herlitz's junctional epidermolysis bullosa patients. Exp Dermatol 1992; 1: 221-229.
27. Bruckner-Tuderman L, Hopfner B, Hammami-Hauasli N,. Biology of anchoring fibrils: lessons from dystrophic epidermolysis bullosa. Matrix Biol 1999; 18: 43-54.
28. Pai S, Marinkovich MP,. Epidermolysis bullosa: new and emerging trends. Am J Clin Dermatol 2002; 3: 371-380.
29. Lapiere JC, Hu L, Iwasaki T, et al. Identification of the epitopes on human type VII collagen for monoclonal antibodies LH 7.2 and clone I, 185. J Dermatol Sci 1994; 8: 145-150.
30. Heagerty AH, Kennedy AR, Leigh IM, et al. Identification of an epidermal basement membrane defect in recessive forms of dystrophic epidermolysis bullosa by LH 7:2 monoclonal antibody: use in diagnosis. Br J Dermatol 1986; 115: 125-131.
31. Leigh IM, Eady RA, Heagerty AH, et al. Type VII collagen is a normal component of epidermal basement membrane, which shows altered expression in recessive dystrophic epidermolysis bullosa. J Invest Dermatol 1988; 90: 639-642.
32. Bruckner-Tuderman L, Mitsuhashi Y, et al. Anchoring fibrils and type VII collagen are absent from skin in severe recessive dystrophic epidermolysis bullosa. J Invest Dermatol 1989; 93: 3-9.
33. Intong LR, Murrell DF,. How to take skin biopsies for epidermolysis bullosa. Dermatol Clin 2010; 28: 197-200.
34. Castiglia D, Zambruno G,. Molecular testing in epidermolysis bullosa. Dermatol Clin 2010; 28: 223-229, vii-viii.